Product Information

DULOXETINE HCL DR 60 MG CAP is a generic product labeled by BluePoint Laboratories, priced at $0.1368 per EA under NDC 68001059608. Its NADAC has been published 157 times since Nov 15, 2023.

FDA first approved this application on Jan 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DULOXETINE HCL DR 60 MG CAP

Duloxetine
$0.1368per EA

Strength

60 mg/1

NDC

68001059608

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DULOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208706

FDA Approved

1/6/2017

TE Code

AB

On Market Since

7/28/2023

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DULOXETINE HCL DR 60 MG CAP has been published 157 times since Nov 15, 2023, and over the history we have for it it has risen 21.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1368 per EA
All-time high$0.1368 (Nov 11, 2026)
All-time low$0.0840 (Nov 20, 2024)
52-week high$0.1368
52-week low$0.0929
Median price$0.1068
Average price$0.1080
Largest weekly change-18.3% (Nov 20, 2024)
Weeks tracked157
Tracking sinceNov 15, 2023

Price History

1W

0.0%

1M

+1.4%

3M

+5.9%

6M

+4.7%

1Y

+45.7%

3Y

+21.3%

5Y

N/A

All

+21.3%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DULOXETINE HCL DR 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 60 MG CAP, manufactured by BluePoint Laboratories, is $0.1368 per EA (NDC 68001059608), effective Nov 11, 2026.

How has the price of DULOXETINE HCL DR 60 MG CAP changed over time?

Over the history we have for it, the NADAC for DULOXETINE HCL DR 60 MG CAP has risen 21.3%. It has been tracked across 157 weekly CMS publications since Nov 15, 2023.

What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 60 MG CAP?

Since Nov 15, 2023, the NADAC for DULOXETINE HCL DR 60 MG CAP has ranged from a low of $0.0840 (Nov 20, 2024) to a high of $0.1368 (Nov 11, 2026), with a median of $0.1068 per EA.

Are there cheaper alternatives to DULOXETINE HCL DR 60 MG CAP?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 60 MG CAP, is $0.1072 per EA — about 22% below DULOXETINE HCL DR 60 MG CAP.

Who manufactures DULOXETINE HCL DR 60 MG CAP?

DULOXETINE HCL DR 60 MG CAP (NDC 68001059608) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.